Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection - Wikidata - wikimedia - TriplyDB

Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection

Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection

http://www.wikidata.org/entity/Q28748901

about

sameAs

Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment.Short-course antiretroviral therapy in primary HIV infection.No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial.Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection.Quantifying the turnover of transcriptional subclasses of HIV-1-infected cells 24 hours in the life of HIV-1 in a T cell line Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytes Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns.Brain alterations within the first 100 days of HIV infection.A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals Administration of Fozivudine tidoxil as a single-agent therapeutic during acute feline immunodeficiency virus infection does not alter chronic infection Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs.Acute HIV-1 infection in the Southeastern United States: a cohort study.Measuring the latent reservoir in vivo.Structural brain alterations can be detected early in HIV infection Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection.Advances and hope for perinatal HIV remission and cure in children and adolescents.Cell-associated HIV RNA: a dynamic biomarker of viral persistence.The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy How to best measure HIV reservoirs?Attacking the HIV reservoir from the immune and viral perspective.Residual inflammation and viral reservoirs: alliance against an HIV cure.Cyclosporine A in addition to standard ART during primary HIV-1 infection: pilot randomized clinical trial.Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter.Paediatric HIV infection: the potential for cure.Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability.Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection.The viral protein Tat can inhibit the establishment of HIV-1 latency.Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection.Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART.Quantification of Total and 2-LTR (Long terminal repeat) HIV DNA, HIV RNA and Herpesvirus DNA in PBMCs.Combining Cell and Gene Therapy in an Effort to Eradicate HIV.HIV sequence diversity during the early phase of infection is associated with HIV DNA reductions during antiretroviral therapy.Delayed linkage to care in one-third of HIV-positive individuals in the Netherlands.The Use of Ultra-Sensitive Molecular Assays in HIV Cure-Related Research.Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.What do we measure when we measure cell-associated HIV RNA.

P2860

Q28742727-B16EEA07-B7F0-4A34-A1AC-0179BCB058DC Q33900251-D002051F-996A-4197-81EE-A1E7980E438F Q34037516-DA79BF64-2849-46FE-8297-C7A4909CF8E1 Q34220902-A83EB0AF-6983-43F9-87D0-BA5734B1EB6F Q34231138-C099D77A-B89E-4939-89FE-B6D1A5446ECF Q34393716-7B9BAA8C-997D-4546-86B5-B004E0661A04 Q34574897-44970682-C83C-4433-A02A-55552C0437FA Q34649701-27F62019-98CE-400D-9260-05FCF51CBF61 Q34976999-F28ECC15-ADDC-421E-A912-B2114B2AABD5 Q34994446-89AAC987-AADD-41EE-80B7-451BEF67AB30 Q36038655-AB3B3B07-136A-4B78-BF2F-5F1AEEC94A52 Q36096407-06B354CA-3F18-48C3-BB94-C20C8AD6A747 Q36311438-1FDDCD7E-4578-49B5-8FEB-46D63E0217A8 Q36311695-573FBC32-19C5-4DDF-9F5F-037B4681A01E Q36509575-FBAFEE9B-2B91-4FBC-A4F8-54212BF07275 Q36515110-D73F7F0A-BE0F-4F8F-B563-0542011F2118 Q36626743-C002A28A-B7FB-4878-9AB4-DA66F29B51B8 Q36736353-E76C6F1B-00B6-42F8-AD75-B1E166A30FCE Q36737063-A912EF75-B3F7-4B6F-AE8E-9647603B19F6 Q36798408-122D2793-1C97-44B9-A59F-F0622C0293FD Q36824388-D367F543-29EA-4354-800D-8A5113B47830 Q37104112-CC69A858-B3BF-4C44-A610-33BB596A4CD5 Q37149147-2DC4A46A-E25C-452F-887C-CC2C68222283 Q38067646-291BA8F0-B296-4BA5-B896-3F00499FA211 Q38269458-AA980CFD-6C01-4830-9434-C0713F63F3D1 Q38383280-BAAAAF3E-09D5-4CCE-9518-6E3BC4B36CB7 Q38591360-F2C4CD10-C1A7-4DED-97DD-A07233CEB989 Q38773102-9F3F8892-3888-4CDE-9F11-C16CAD599F01 Q39357415-6EDF4F96-BAA2-46D3-B9AE-735D37383EBA Q39398170-9CD14CF3-4E44-4480-A01B-7BD5CFBFCDDE Q39413458-CE9E694D-2B00-4FD4-A539-05BD69190C9C Q40151311-695E31E0-F0C5-4D54-ABEA-15FA379BF87C Q40192992-3C3B2E50-CB22-4C7E-8C2F-127E7E4988A5 Q40394431-8CA28F6F-607B-442E-9BB2-4A7377B247AF Q40427938-DB16E97E-8877-4B48-BF69-BA409DF2BF62 Q40478109-594A0E77-D0DF-437A-8EDE-4C8B32DA4FD5 Q40949590-B4E66B27-C362-4663-869A-9FF8E3396A17 Q42037424-9E6771D2-4EB1-4EE2-A37B-CB7C4C64159D Q45930474-8E1568EC-3A8E-4956-9462-633C27DC6300 Q47548192-A2861773-EEF6-4E40-B4B7-871B9901DF8E

P2860

Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection

http://www.wikidata.org/entity/Q28748901

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Profound depletion of HIV-1 tr ...... therapy during acute infection

@ast

Profound depletion of HIV-1 tr ...... therapy during acute infection

@en

Profound depletion of HIV-1 tr ...... therapy during acute infection

@nl

type

label

Profound depletion of HIV-1 tr ...... therapy during acute infection

@ast

Profound depletion of HIV-1 tr ...... therapy during acute infection

@en

Profound depletion of HIV-1 tr ...... therapy during acute infection

@nl

prefLabel

Profound depletion of HIV-1 tr ...... therapy during acute infection

@ast

Profound depletion of HIV-1 tr ...... therapy during acute infection

@en

Profound depletion of HIV-1 tr ...... therapy during acute infection

@nl

P1433

Q28748901-AB0B87B9-CDC3-4670-AE86-18D1133120C9

P1476

Q28748901-F3628B11-3D6C-41E7-BC2B-C0CC8F44181B

P2093

Q28748901-1846DB1F-AF50-4539-8055-8B72D84B64FC

Q28748901-29CE2553-7A27-4D79-8387-A8F777AD1A97

Q28748901-380AB240-C11E-47D4-A3CB-8D10901EB845

Q28748901-38505595-FF1B-4FE5-889B-A19AE07F5065

Q28748901-3AB53287-A325-4CE7-88E2-FA01408901EB

Q28748901-5042B6D3-C9FA-4E61-8063-BEEBD94DA78A

Q28748901-6EAC4AF2-267A-4EE4-8044-CDBE1E5D3743

Q28748901-ACDECB26-E1D3-4B0E-9A78-0AEC59014EE8

Q28748901-CC839091-7FC0-4756-AD75-31AAF998E8CA

Q28748901-D97AD3F7-3FF8-41F8-887B-6AFB660D3D77

P2860

Q28748901-054A8080-560F-4706-B771-C79D4D03C2D2

Q28748901-096CFD37-C746-449D-A1AB-6E6BE63FB1A8

Q28748901-0AE22156-1D60-4053-A90B-77956A431013

Q28748901-0CF7772B-5913-43D2-BE0F-122FE05B2EF4

Q28748901-0F057BD7-C098-4FA1-9EE7-D1090F480C2E

Q28748901-13C7C2AB-C091-42DD-B05B-879D9FB41E64

Q28748901-1B75CB6D-63ED-4E27-B532-4DF409C0A13D

Q28748901-206CA0CE-940D-4F01-8A44-BEAC2B71CF57

Q28748901-29E7BADD-E2B7-423E-AEB3-FB87D5DCE1C9

Q28748901-2AAB938D-38F5-434C-BB5F-E90C0AA8DBB1

P304

Q28748901-A711F13B-B17F-4F7D-BD0F-F207A01BEB17

P31

Q28748901-EF934960-1689-41FA-B30A-E86D2B932220

P3181

Q28748901-37896F5F-0827-4518-811A-16A9BAF431D2

P356

Q28748901-8053CAC3-BD3B-40E0-9850-A98694B13E04

P407

Q28748901-F1808914-B713-431C-AC15-954FCF55B309

P433

Q28748901-99539A0F-69DF-461D-AAD5-2F2A717F80E1

P478

Q28748901-8B4F53EB-81AC-4D1E-B476-A39D02959C77

P50

Q28748901-0520F47F-971E-4566-937A-2473D2B62D95

Q28748901-8432DD22-F706-4D47-A778-A6CBB7F5366E

Q28748901-8D0FA6D6-D56E-41D7-A52D-EE3822E4B193

P577

Q28748901-812FA36F-3799-4782-A31C-E763E86000E9

P5875

Q28748901-BAAA0C15-2D7F-4350-9EC9-36C47389AC18

P698

Q28748901-5D0EBD22-1A72-452C-9BB7-89AB63103B42

P921

Q28748901-EE4C29CB-0889-47F0-9979-B81B0C19C886

P932

Q28748901-DF5335A8-34C7-4941-986F-E769DBC2991E

P3181

P356

JOURNAL.PONE.0013310

P1433

P1476

Profound depletion of HIV-1 tr ...... therapy during acute infection

@en

P2093

Adrian Schmid

http://www.w3.org/2001/XMLSchema#string

Alexandra U Scherrer

http://www.w3.org/2001/XMLSchema#string

Barbara Niederöst

http://www.w3.org/2001/XMLSchema#string

Beda Joos

http://www.w3.org/2001/XMLSchema#string

Christina Grube

http://www.w3.org/2001/XMLSchema#string

Claudia F Althaus

http://www.w3.org/2001/XMLSchema#string

Marek Fischer

http://www.w3.org/2001/XMLSchema#string

Philip Rieder

http://www.w3.org/2001/XMLSchema#string

Rainer Weber

http://www.w3.org/2001/XMLSchema#string

Sara Gianella

http://www.w3.org/2001/XMLSchema#string

P2860

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

HIV superinfection

Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006.

Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity.

Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.

P304

e13310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1838469

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0013310

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Huldrych F Günthard

Karin J Metzner

P577

2010-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47520950

http://www.w3.org/2001/XMLSchema#string

P698

20967271

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2953504

http://www.w3.org/2001/XMLSchema#string